TRAD CHI MED (00570): Huang Hao appointed as non-executive director.
Chinese Herbal Medicine (00570) announced that the board of directors made a resolution on January 15, 2025, due to adjustments in job responsibilities...
TRAD CHI MED (00570) has announced that the board of directors made a resolution on January 15, 2025, due to adjustments in job responsibilities, Mr. Yang Binghua, Mr. Wang Kan, Mr. Meng Qingxin, Ms. Li Ru, Mr. Yang Wenming, and Mr. Cheng Xueren have resigned as non-executive directors, and the arrangements are effective immediately. After resigning as non-executive directors, Mr. Yang Binghua will no longer serve as a member of the Nomination Committee, and Mr. Yang Wenming and Mr. Cheng Xueren will no longer serve as members of the Strategic Committee.
Effective from January 15, 2025, Mr. Liu Haijian has been appointed as a non-executive director and a member of the Nomination Committee; Mr. Li Xiangrong has been appointed as a non-executive director and a member of the Strategic Committee; Mr. Zhu Jing has been appointed as a non-executive director and a member of the Strategic Committee; Ms. Xu Jinghui has been appointed as a non-executive director and a member of the Audit Committee; and Mr. Huang Hao has been appointed as a non-executive director.
Related Articles

ZYLOXTB (02190) spent HKD 1.2923 million to repurchase 50,000 shares on September 15th.

BlackRock increased its holdings in SINOPEC SEG (02386) by 2,481,500 shares, at a price of approximately 7.3 Hong Kong dollars per share.

E Fund Fund increased its holding of CMSC (06099) by 1,589,600 shares, with a price per share of approximately HK$17.4.
ZYLOXTB (02190) spent HKD 1.2923 million to repurchase 50,000 shares on September 15th.

BlackRock increased its holdings in SINOPEC SEG (02386) by 2,481,500 shares, at a price of approximately 7.3 Hong Kong dollars per share.

E Fund Fund increased its holding of CMSC (06099) by 1,589,600 shares, with a price per share of approximately HK$17.4.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025